Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea.
Young-Hwan AhnHyungcheol ParkMyeon Jae LeeDong Hyun KimSung Bum ChoEunae ChoChung Hwan JunSung Kyu ChoiPublished in: Gut and liver (2020)
Treatment efficacy was not different between the leprosy-affected population and the general population. However, severe ribavirin-induced hemolytic anemia requiring transfusion was present in 28.5% of genotype 2 patients. Therefore, we suggest ribavirin-free DAAs for the treatment of genotype 2 hepatitis C in leprosy-affected persons in the future.